EU Poison-Centre Notification and UFI Change Control for Private-Label Mixtures

For a European B2B buyer launching or changing a hazardous private-label mixture, the key question is not simply whether a label can be printed on time. The product identity, composition, Unique Formula Identifier (UFI), poison-centre notification and market information need to remain connected. ECHA explains that the UFI links a mixture placed on the market with information submitted to appointed bodies. That makes the identifier a controlled data point, rather than a generic artwork field that can be copied between products.

This article is a procurement and change-control guide, not a determination of whether a specific mixture is in scope or compliant. Under ECHA’s poison-centre information, importers and downstream users placing hazardous mixtures on the market have notification responsibilities in the Member States where the mixture is placed on the market. The responsible legal entity should obtain competent regulatory advice for the specific product, classification, intended use and countries. A buyer can nevertheless build a much better supply process by asking the right identity and change questions before an order, reformulation or relabelling event.

Start with the commercial role and the actual mixture

Map the proposed supply chain before calling a product “private label.” Identify the legal entity that will place the mixture on the market, the manufacturer and filler where relevant, the product trade name, formulation identity, classification, intended user type, destination countries, package formats and label languages. Keep each item tied to a controlled internal product identifier. A marketing name alone is insufficient where several concentrations, fragrances, colours, package sizes or formulations may be in circulation.

ECHA states that a UFI corresponds to one mixture composition; products sharing the same composition can use the same UFI. It also explains that products labelled with the same UFI must have the same mixture composition. This is why procurement should not reuse an identifier merely because a new product looks commercially similar. A changed solvent, additive, concentration or mixture-in-mixture source may require a regulatory assessment even if the sales name, pack size and headline performance description remain unchanged.

Make a release file that links the proposed product to custom chemical supply, then separates commercial facts from regulatory evidence. Commercial facts include name, quantity, pack and destination. Controlled evidence can include the current SDS, label text, product specification, composition version, UFI assignment record, notification status supplied by the responsible party and approved artwork. This keeps an attractive label proof from being mistaken for evidence that the underlying mixture data are current.

Understand what the UFI does—and what it does not do

The UFI is designed to create an unambiguous link between a mixture and the information available for emergency health response. ECHA says the code is generated using a company VAT number, or a company key in certain cases, and a mixture-specific formulation number. ECHA also says the code should be displayed with the prefix “UFI:” and that a product should not be placed on the market with an unnotified UFI. Those points make UFI control operationally important for label approval and release planning.

The UFI is not a certificate of product performance, a universal safety approval or a substitute for a current SDS. It also does not reveal the formula to a customer. Treat it as an identifier with a defined relationship to a composition and a notification. Do not use a supplier’s UFI as a shorthand conclusion that a downstream private-label product, repacked material or newly formulated blend requires no further assessment. The role of each entity and the actual mixture configuration matter.

For a UFI change control hazardous mixture process, retain the formulation number, UFI, formula version, product identifiers, label revision and the responsible approval owner together. Restrict who can generate or change those values. If an ERP, artwork or specification system holds a copied UFI, reconcile it against the controlled source before release. A transcription error can create a product identity problem even where the chemistry has not changed.

Build a notification-ready information pack early

ECHA’s Annex VIII materials describe harmonised information requirements for poison-centre notifications, including full mixture composition and a UFI. Its guidance also highlights product and market information, and the ECHA submission route. Do not wait for finished artwork to assemble the inputs. At formulation or sourcing stage, request the material identities, concentration information, hazard data, toxicological information where applicable, product category, packaging and intended market information through the designated regulatory owner.

The appropriate data package depends on the product and applicable route. The useful procurement control is to ask which fields are needed, who owns them, what their source is and which revision is approved. Where a confidential mixture-in-mixture is involved, ECHA describes conditions under which a UFI can support the supply chain. That does not remove the need to check whether the required notification information and legal responsibilities are in place for the final product.

Use controlled documentation to record document versions, source party, review date and release decision. A clear matrix helps: formulation owner supplies the current composition; regulatory owner assesses notification and market requirements; quality controls document revisions; artwork owner applies approved content; procurement prevents an unreviewed substitute; and operations releases only the approved pack. The exact allocation varies by business, but unassigned ownership is a predictable source of late changes.

Make composition changes visible before they reach artwork

A poison centre notification composition change workflow should start with a formal change request, not a revised label PDF. Capture every proposed change: added, deleted or substituted component; concentration movement; changed mixture-in-mixture supplier or UFI; new product trade name; product-category change; pack change; market addition; new language; classification update; or new use profile. Describe the current and proposed state, effective date, inventory impact and whether existing packs may remain in circulation.

ECHA explains that certain component-concentration changes may be allowed within Annex VIII variation limits, while other changes require an update and new UFI. The exact rule depends on how the component was declared and the applicable requirements; it should be assessed by the responsible expert, not guessed from a generic tolerance table. The buyer’s job is to give that reviewer complete, versioned information before production and to hold release until required approvals are documented.

Separate a formula change from a packaging-only change, but do not assume packaging is irrelevant. ECHA’s UFI guidance notes that products with the same composition may share a UFI, yet the notification also needs accurate product information. A new pack, trade name or market can affect the controlled data and label workflow. Check the approved notification and local requirements rather than assuming a new label size or destination leaves every other record unchanged.

Use a release gate that procurement can follow

Before a purchase order becomes a routine release, verify that the ordered mixture, formula version, UFI, label revision, SDS revision, destination, product category and package all match the approved record. Verify who has confirmed the notification status and whether the intended release date is permitted. Maintain the existing supplier-change procedure: a new source, filler, manufacturing site, solvent grade, concentration range, specification or batch convention should be routed to the same assessment rather than treated as a normal commercial substitution.

For a CLP Annex VIII private label chemicals launch, require evidence of the decision rather than an informal confirmation in an email. The record can be concise: proposed product; legal entity and markets; composition version; UFI; controlled artwork; regulatory assessment reference; notification status; SDS; pack; effective date; inventory disposition; approvers; and post-launch review trigger. It should not contain credentials, confidential formula detail beyond the people who need it, or a claim that a supplier has made a legal conclusion for the buyer.

Link lot and release information through batch traceability. When a customer, poison centre or internal team asks which mixture was distributed, a traceable record should connect the product code, lot, pack, label and controlled formulation—not merely a product family name.

Private-label UFI checklist

• Identify the placing-on-market entity, exact mixture, formula version, trade name, user type, destination countries and pack.
• Assign and control the UFI as a composition-linked identifier, not a reusable artwork field.
• Assemble composition, hazard, product, packaging and market data early through the responsible regulatory owner.
• Keep SDS, label, formula, UFI and notification-status records on controlled revisions.
• Route component, concentration, mixture-in-mixture, market and product-information changes through formal assessment before release.
• Do not infer notification scope or legal compliance from a UFI, SDS or supplier statement alone.
• Match the purchase order, received material, lot, pack and approved label to the release record.
• Retain evidence and review it when suppliers, formulae, sites, packs or markets change.

A disciplined European chemical mixture notification workflow reduces preventable rework while leaving legal conclusions with the accountable experts. For a defined private-label product, connect custom-supply planning, quality controls and request a documentation review.